Angiopoietin-1 mediates inhibition of hypertension-induced release of angiopoietin-2 from endothelial cells.

AIMS Adequate endothelial cell stimulation is a prerequisite for the adaptive remodelling of macro- and microvessels. A pivotal autocrine mechanism following endothelial cell activation is the release of angiopoietin-2 (Ang-2), which subsequently antagonizes the binding of Ang-1 to the Tie-2 receptor, thus sensitizing the endothelial cells to pro-angiogenic and/or pro-inflammatory stimuli. Based on the observation that hypertension in mice reduces the abundance of Ang-2 stored in arterial endothelial cells, this study was aimed at testing the hypothesis that an increase in wall stress (WS) or stretch-a hallmark of hypertension-is sufficient to release Ang-2 from endothelial cells. METHODS AND RESULTS In fact, stretching of isolated perfused mouse arteries or human cultured endothelial cells rapidly elicited an increased release of Ang-2. In the cultured endothelial cells, this was preceded by a transient rise in intracellular free calcium, abrogated through calcium chelation and accompanied by a decrease in Tie-2 phosphorylation. Interestingly, Ang-1 abolished the stretch-induced release of Ang-2 from both cultured and native endothelial cells through inhibiting the stretch-dependent mobilization of intracellular calcium. CONCLUSION Collectively, these results indicate that increased WS or stretch facilitates the release of Ang-2 from endothelial cell Weibel-Palade bodies, and that Ang-1 can block this by attenuating the stretch-mediated rise in intracellular calcium.

[1]  V. Mohan,et al.  Angiopoietin-2 levels in glucose intolerance, hypertension, and metabolic syndrome in Asian Indians (Chennai Urban Rural Epidemiology Study-74). , 2010, Metabolism: clinical and experimental.

[2]  M. Hecker,et al.  Upregulation of Glutathione Peroxidase Offsets Stretch-Induced Proatherogenic Gene Expression in Human Endothelial Cells , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[3]  D. Fliser,et al.  Circulating angiopoietin-2 in essential hypertension: relation to atherosclerosis, vascular inflammation, and treatment with olmesartan/pravastatin , 2009, Journal of hypertension.

[4]  A. Malik,et al.  Role of H2O2-activated TRPM2 calcium channel in oxidant-induced endothelial injury , 2009, Thrombosis and Haemostasis.

[5]  M. Hecker,et al.  Stretch-Induced Activation of the Transcription Factor Activator Protein-1 Controls Monocyte Chemoattractant Protein-1 Expression During Arteriogenesis , 2008, Circulation research.

[6]  Y. Suh,et al.  Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor , 2008, Cardiovascular research.

[7]  G. Lip,et al.  Angiopoietin‐2 levels as a biomarker of cardiovascular risk in patients with hypertension , 2008, Annals of medicine.

[8]  M. Hecker,et al.  Cyclic Stretch Controls the Expression of CD40 in Endothelial Cells by Changing Their Transforming Growth Factor–&bgr;1 Response , 2007, Circulation.

[9]  D. Ogden,et al.  Rate, extent and concentration dependence of histamine‐evoked Weibel–Palade body exocytosis determined from individual fusion events in human endothelial cells , 2007, The Journal of physiology.

[10]  K. Plate,et al.  Angiopoietin-2 Impairs Revascularization After Limb Ischemia , 2007, Circulation research.

[11]  S. Usami,et al.  Mechanisms of induction of endothelial cell E-selectin expression by smooth muscle cells and its inhibition by shear stress. , 2007, Blood.

[12]  H. Augustin,et al.  Angiopoietins: a link between angiogenesis and inflammation. , 2006, Trends in immunology.

[13]  H. Augustin,et al.  Angiopoietin-2 sensitizes endothelial cells to TNF-α and has a crucial role in the induction of inflammation , 2006, Nature Medicine.

[14]  Xiao-pei Gao,et al.  Angiopoietin-1 Opposes VEGF-Induced Increase in Endothelial Permeability by Inhibiting TRPC1-Dependent Ca2+ Influx , 2005, Circulation research.

[15]  S. Usami,et al.  Shear Stress Inhibits Smooth Muscle Cell–Induced Inflammatory Gene Expression in Endothelial Cells: Role of NF-&kgr;B , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[16]  H. Augustin,et al.  The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism , 2005, Journal of Cell Science.

[17]  J. Gamble,et al.  Role of protein kinase Czeta in thrombin-induced endothelial permeability changes: inhibition by angiopoietin-1. , 2004, Blood.

[18]  Yi Wei,et al.  Angiopoietin-1 modulates endothelial cell function and gene expression via the transcription factor FKHR (FOXO1). , 2004, Genes & development.

[19]  H. Augustin,et al.  The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. , 2004, Blood.

[20]  G. Fink,et al.  Endothelin-1 Stimulates Arterial VCAM-1 Expression Via NADPH Oxidase-Derived Superoxide in Mineralocorticoid Hypertension , 2003, Hypertension.

[21]  E. Schiffrin,et al.  ETA Receptor Blockade Decreases Vascular Superoxide Generation in DOCA-Salt Hypertension , 2003, Hypertension.

[22]  L. Ellis,et al.  Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. , 2003, Cancer research.

[23]  Steven M. Holland,et al.  Mechanical Stretch Enhances mRNA Expression and Proenzyme Release of Matrix Metalloproteinase‐2 (MMP‐2) via NAD(P)H Oxidase‐Derived Reactive Oxygen Species , 2003, Circulation research.

[24]  M. Rondaij,et al.  Real-Time Imaging of the Dynamics and Secretory Behavior of Weibel-Palade Bodies , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[25]  G. Thurston.  Complementary actions of VEGF and Angiopoietin‐1 on blood vessel growth and leakage * , 2002, Journal of anatomy.

[26]  M. Skobe,et al.  Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth. , 2002, The American journal of pathology.

[27]  M. Hecker,et al.  17β‐Estradiol inhibition of NADPH oxidase expression in human endothelial cells , 2001 .

[28]  G. Koh,et al.  Angiopoietin-1 Reduces VEGF-Stimulated Leukocyte Adhesion to Endothelial Cells by Reducing ICAM-1, VCAM-1, and E-Selectin Expression , 2001, Circulation research.

[29]  H. Augustin,et al.  Blood vessel maturation in a 3‐dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[30]  J. Gamble,et al.  Angiopoietin-1 Is an Antipermeability and Anti-Inflammatory Agent In Vitro and Targets Cell Junctions , 2000, Circulation research.

[31]  R. Jain,et al.  Leaky vessels? Call Ang1! , 2000, Nature Medicine.

[32]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[33]  G. Garcı́a-Cardeña,et al.  Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[34]  C. Pereira,et al.  The protective effect of vitamin E, idebenone and reduced glutathione on free radical mediated injury in rat brain synaptosomes. , 1998, Biochemical and biophysical research communications.

[35]  J. Zweier,et al.  Hydrogen peroxide induces intracellular calcium oscillations in human aortic endothelial cells. , 1998, Circulation.

[36]  G. Schmid-Schönbein,et al.  Oxidative stress in the Dahl hypertensive rat. , 1997, Hypertension.

[37]  D. Atsma,et al.  Involvement of calcium and G proteins in the acute release of tissue-type plasminogen activator and von Willebrand factor from cultured human endothelial cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[38]  P. Kubes,et al.  A balance between nitric oxide and oxidants regulates mast cell-dependent neutrophil-endothelial cell interactions. , 1996, Circulation research.

[39]  C. Alpers,et al.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.

[40]  C. Wollheim,et al.  Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells. , 1995, Blood.

[41]  P. Kubes,et al.  Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. , 1994, Circulation research.

[42]  M. Davies,et al.  The expression of the adhesion molecules ICAM‐1, VCAM‐1, PECAM, and E‐selectin in human atherosclerosis , 1993, The Journal of pathology.

[43]  A. Blann,et al.  von Willebrand factor and endothelial damage in essential hypertension. , 1993, Journal of human hypertension.

[44]  Keiji Naruse,et al.  Involvement of stretch-activated ion channels in Ca2+ mobilization to mechanical stretch in endothelial cells. , 1993, The American journal of physiology.

[45]  David John Adams,et al.  Ion channels and regulation of intracellular calcium in vascular endothelial cells , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  D. Wagner,et al.  Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells , 1982, The Journal of cell biology.

[47]  M. Hecker,et al.  17beta-estradiol inhibition of NADPH oxidase expression in human endothelial cells. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  D. L. Wang,et al.  Cyclic strain-induced reactive oxygen species involved in ICAM-1 gene induction in endothelial cells. , 1998, Hypertension.